Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chiron Lands Lance As CEO; Biotech Firm Seeking To Sharpen Image

Executive Summary

Chiron is turning to former Glaxo Chief Operating Officer Sean Lance to help sharpen its image with investors - and to manage a transition in its relationship with Novartis.

You may also be interested in...



Chiron Taps GSK International Pharma Head Pien For CEO Post

GlaxoSmithKline International Pharmaceuticals President Howard Pien will join Chiron as CEO and president by the end of April

Chiron Taps GSK International Pharma Head Pien For CEO Post

GlaxoSmithKline International Pharmaceuticals President Howard Pien will join Chiron as CEO and president by the end of April

Glaxo SmithKline U.S. Management Will Be Early Test Of Integration Process

Glaxo SmithKline's U.S. management team is to be worked out during the merger integration process between the two companies.

UsernamePublicRestriction

Register

PS031890

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel